Table 1.
Demographic characteristics of the two groups.
| Characteristics | Pancreatitis with jaundice | Pancreatitis without jaundice | p-value for CI 99% |
|---|---|---|---|
| N = 1,267,744 | N = 8855 (0.7%) | N = 1,258,889 (99.3%) | |
| Age | <0.0001 | ||
| Mean years (mean ± SD) | 57.8 ± 17.6 | 53.6 ± 16.8 | |
| Gender | <0.0001 | ||
| Male | 59.1% | 52.3% | |
| Female | 40.9% | 47.7% | |
| ∗Missing—475 | |||
| Age groups (years) | <0.0001 | ||
| 18–44 | 23.7% | 30.6% | |
| 45–64 | 38.2% | 42.9% | |
| 65–84 | 32% | 22.3% | |
| ≥85 | 6.1% | 4.1% | |
| Race | <0.0001 | ||
| Caucasians | 67.4% | 61.9% | |
| African Americans | 9.6% | 16.8% | |
| Others | 23% | 21.3% | |
| ∗Missing—10 | |||
| Insurance type | <0.0001 | ||
| Medicare | 40.9% | 36.3% | |
| Medicaid | 17.2% | 24.3% | |
| Private | 31.8% | 27.9% | |
| Other | 9.9% | 11.4% | |
| ∗Missing—75 | |||
| Elixhauser comorbidities | |||
| Congestive heart failure | 8.2% | 7.4% | 0.003 |
| Peripheral vascular disease | 3.3% | 3.6% | 0.25 |
| Paralysis | 1.1% | 1.5% | 0.001 |
| Other neurological disorders | 4.9% | 6.8% | <0.0001 |
| Chronic pulmonary disease | 10.5% | 16.5% | <0.0001 |
| Hypertension | 49.1% | 53.1% | <0.0001 |
| Diabetes mellitus | 20.8% | 27.1% | <0.0001 |
| Hypothyroidism | 7.2% | 8.5% | <0.0001 |
| Renal failure | 8.3% | 10.7% | <0.0001 |
| Liver disease | 8.6% | 15.2% | <0.0001 |
| Peptic ulcer disease chronic | 2.6% | 1.9% | <0.0001 |
| Metastatic cancer | 3.8% | 1.5% | <0.0001 |
| Solid tumor w/out metastasis | 3.9% | 1.7% | <0.0001 |
| Coagulopathy | 13.4% | 8.9% | <0.0001 |
| Weight loss | 12.3% | 9.8% | <0.0001 |
| Fluid and electrolyte disorders | 42.9% | 39.9% | <0.0001 |
| Chronic blood loss anemia | 0.8% | 0.7% | 0.65 |
| Deficiency anemias | 17.7% | 15.9% | <0.0001 |
| Alcohol abuse | 16.9% | 23.7% | <0.0001 |
| Drug abuse | 3.3% | 6.2% | <0.0001 |
| Depression | 7.1% | 13.8% | <0.0001 |
| Liver cancer | 1.9% | 0.4% | <0.0001 |
| Pancreatic cancer | 4.9% | 1.2% | <0.0001 |
| Age of diagnosis (pancreatic cancer patients) | 62.7 ± 12.8 | 67.5 ± 10.5 | |
| Cholangiocarcinoma | 1.5% | 0.1% | <0.0001 |
| Smoking | 32.7% | 37.9% | <0.0001 |
| Antibiotic use | 0.2% | 0.3% | 0.05 |
| Biliary stone | 36.2% | 16.7% | <0.0001 |
| ERCP | 4.3%0 | 0.9% | <0.0001 |
| Endoscopic sphincterotomy | 2.2% | 0.2% | <0.0001 |
| Percutaneous cholecystostomy | 1.2% | 0.3% | <0.0001 |
| Cholecystectomy | 19.5% | 11.2% | <0.0001 |
| Admission type | 0.01 | ||
| Emergent | 93.7% | 94.3% | |
| Elective | 6.3% | 5.7% | |
| ∗Missing—2880 | |||
| Hospital ownership/control | <0.0001 | ||
| Rural | 7.8% | 10% | |
| Urban nonteaching | 26.3% | 26.6% | |
| Urban teaching | 65.9% | 63.4% |